中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
11期
64-66,67
,共4页
宁辉%孙霞%王茜%纪向虹
寧輝%孫霞%王茜%紀嚮虹
저휘%손하%왕천%기향홍
内脂素%妊娠期糖尿病%胰岛素抵抗%胎盘%脐血
內脂素%妊娠期糖尿病%胰島素牴抗%胎盤%臍血
내지소%임신기당뇨병%이도소저항%태반%제혈
Visfatin%Gestational diabetes mellitus%Insulin resistance%Placenta%Umbilical cord blood
目的:探讨妊娠期糖尿病(GDM)母婴血清内脂素水平、胎盘及网膜脂肪组织内脂素基因表达及其与胎儿生长发育的关系。方法:采用双抗体夹心酶联免疫吸附法测定40例妊娠期糖尿病及55例正常孕妇母血清及新生儿脐血血清中内脂素水平;采用实时荧光定量聚合酶链反应(Real-time PCR)检测两组胎盘及网膜脂肪组织内脂素mRNA的表达。结果:(1)GDM组孕妇产前BMI、孕期体重增长、新生儿出生体重高于对照组,差异有统计学意义(P<0.05);(2)GDM组孕妇血清内脂素水平显著高于对照组,差异有统计学意义(P<0.05);GDM组新生儿脐血血清内脂素水平显著高于对照组,差异有统计学意义(P<0.05);组内比较,两组脐血内脂素水平均显著高于母血内脂素水平,差异有统计学意义(P<0.05);(3)两组胎盘组织内脂素mRNA表达有显著差异,双△Ct法进行相对定量分析,GDM组内脂素mRNA表达量是对照组的7.826倍;两组网膜脂肪组织内脂素mRNA表达比较差异无统计学意义(P>0.05)。结论:GDM孕妇血清及脐血内脂素水平的升高可能参与了GDM的发生发展以及胎儿宫内发育的调节,循环中内脂素的变化主要来自于胎盘内脂素基因表达的变化。
目的:探討妊娠期糖尿病(GDM)母嬰血清內脂素水平、胎盤及網膜脂肪組織內脂素基因錶達及其與胎兒生長髮育的關繫。方法:採用雙抗體夾心酶聯免疫吸附法測定40例妊娠期糖尿病及55例正常孕婦母血清及新生兒臍血血清中內脂素水平;採用實時熒光定量聚閤酶鏈反應(Real-time PCR)檢測兩組胎盤及網膜脂肪組織內脂素mRNA的錶達。結果:(1)GDM組孕婦產前BMI、孕期體重增長、新生兒齣生體重高于對照組,差異有統計學意義(P<0.05);(2)GDM組孕婦血清內脂素水平顯著高于對照組,差異有統計學意義(P<0.05);GDM組新生兒臍血血清內脂素水平顯著高于對照組,差異有統計學意義(P<0.05);組內比較,兩組臍血內脂素水平均顯著高于母血內脂素水平,差異有統計學意義(P<0.05);(3)兩組胎盤組織內脂素mRNA錶達有顯著差異,雙△Ct法進行相對定量分析,GDM組內脂素mRNA錶達量是對照組的7.826倍;兩組網膜脂肪組織內脂素mRNA錶達比較差異無統計學意義(P>0.05)。結論:GDM孕婦血清及臍血內脂素水平的升高可能參與瞭GDM的髮生髮展以及胎兒宮內髮育的調節,循環中內脂素的變化主要來自于胎盤內脂素基因錶達的變化。
목적:탐토임신기당뇨병(GDM)모영혈청내지소수평、태반급망막지방조직내지소기인표체급기여태인생장발육적관계。방법:채용쌍항체협심매련면역흡부법측정40례임신기당뇨병급55례정상잉부모혈청급신생인제혈혈청중내지소수평;채용실시형광정량취합매련반응(Real-time PCR)검측량조태반급망막지방조직내지소mRNA적표체。결과:(1)GDM조잉부산전BMI、잉기체중증장、신생인출생체중고우대조조,차이유통계학의의(P<0.05);(2)GDM조잉부혈청내지소수평현저고우대조조,차이유통계학의의(P<0.05);GDM조신생인제혈혈청내지소수평현저고우대조조,차이유통계학의의(P<0.05);조내비교,량조제혈내지소수평균현저고우모혈내지소수평,차이유통계학의의(P<0.05);(3)량조태반조직내지소mRNA표체유현저차이,쌍△Ct법진행상대정량분석,GDM조내지소mRNA표체량시대조조적7.826배;량조망막지방조직내지소mRNA표체비교차이무통계학의의(P>0.05)。결론:GDM잉부혈청급제혈내지소수평적승고가능삼여료GDM적발생발전이급태인궁내발육적조절,순배중내지소적변화주요래자우태반내지소기인표체적변화。
Objective:To study the visfatin levels in gestational diabetes maternal patient’s serum,and cord blood, also the expression of visfatin gene of placenta and adipose tissue with respect to the health of fetal. Method:The visfatin level in maternal serum and umbilical cord blood were determined by ELISA method for 40 cases of gestational diabetes and 55 cases of normal pregnant women. The expression of placenta and adipose tissue visfatin mRNA were studied by real-time fluorescence quantitative polymerase chain reaction(Real-time PCR). Result:(1)The BMI,pregnancy weight gain and neonatal birth weight of the GDM group were higher than the control group,the differences were statistically significant (P<0.05).(2)Serum visfatin level of the GDM group was significantly higher than that in the control group,the difference was statistically significant(P<0.05);neonatal umbilical cord blood serum visfatin level of the GDM group was significantly higher than that in the control group,the difference was statistically significant(P<0.05).(3)The expression of placental tissue visfatin mRNA in the two groups was significantly different,double delta Ct method for relative quantitative analysis, expression amount of visfatin mRNA in the GDM group was 7.826 times higher than that of the control group. Expression of omental adipose tissue visfatin mRNA of two groups had no significant difference(P>0.05). Conclusion:The increase of visfatin level in serum and umbilical cord may result from the pathogenesis of GDM and the regulation of fetal growth. The change in circulating visfatin level is mainly because the placenta visfatin gene expression.